Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (Clinical Infectious Diseases (2007) 45, (883-893))

P. G. Pappas, C. M.F. Rotstein, R. F. Betts, M. Nucci, D. Talwar, J. J. De Waele, J. A. Vazquez, B. F. Dupont, D. L. Horn, L. Ostrosky-Zeichner, A. C. Reboli, B. Suh, R. Digumarti, C. Wu, L. L. Kovanda, L. J. Arnold, D. N. Buell

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalClinical Infectious Diseases
Volume47
Issue number2
DOIs
StatePublished - Jul 15 2008
Externally publishedYes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Pappas, P. G., Rotstein, C. M. F., Betts, R. F., Nucci, M., Talwar, D., De Waele, J. J., Vazquez, J. A., Dupont, B. F., Horn, D. L., Ostrosky-Zeichner, L., Reboli, A. C., Suh, B., Digumarti, R., Wu, C., Kovanda, L. L., Arnold, L. J., & Buell, D. N. (2008). Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (Clinical Infectious Diseases (2007) 45, (883-893)). Clinical Infectious Diseases, 47(2). https://doi.org/10.1086/590000